For example, IL-10 mRNA levels in serum are increased in MS patients in comparison to healthy controls (83–85), and in PBMCs IL10 mRNA levels are increased 2 weeks post-MSrelapse but subsequently return back to baseline after 4 weeks (64). Here, IL10 is linked to myeloid sarcoma.